Literature DB >> 29797574

Bone marrow mesenchymal stem cell donors with a high body mass index display elevated endoplasmic reticulum stress and are functionally impaired.

Baris Ulum1, Hikmet Taner Teker1, Aysun Sarikaya1, Gunay Balta1,2, Baris Kuskonmaz2, Duygu Uckan-Cetinkaya1,2, Fatima Aerts-Kaya1.   

Abstract

Bone marrow mesenchymal stem cells (BM-MSCs) are promising candidates for regenerative medicine purposes. The effect of obesity on the function of BM-MSCs is currently unknown. Here, we assessed how obesity affects the function of BM-MSCs and the role of endoplasmic reticulum (ER) stress and the unfolded protein response (UPR) therein. BM-MSCs were obtained from healthy donors with a normal (<25) or high (>30) body mass index (BMI). High-BMI BM-MSCs displayed severely impaired osteogenic and diminished adipogenic differentiation, decreased proliferation rates, increased senescence, and elevated expression of ER stress-related genes ATF4 and CHOP. Suppression of ER stress using tauroursodeoxycholic acid (TUDCA) and 4-phenylbutyrate (4-PBA) resulted in partial recovery of osteogenic differentiation capacity, with a significant increase in the expression of ALPL and improvement in the UPR. These data indicate that BMI is important during the selection of BM-MSC donors for regenerative medicine purposes and that application of high-BMI BM-MSCs with TUDCA or 4-PBA may improve stem cell function. However, whether this improvement can be translated into an in vivo clinical advantage remains to be assessed.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  4-phenylbutyrate; body mass index; bone marrow mesenchymal stem cells; endoplasmic reticulum stress; tauroursodeoxycholic acid

Mesh:

Substances:

Year:  2018        PMID: 29797574     DOI: 10.1002/jcp.26804

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  5 in total

Review 1.  Optimization of Mesenchymal Stromal Cell (MSC) Manufacturing Processes for a Better Therapeutic Outcome.

Authors:  Maria Eugenia Fernández-Santos; Mariano Garcia-Arranz; Enrique J Andreu; Ana Maria García-Hernández; Miriam López-Parra; Eva Villarón; Pilar Sepúlveda; Francisco Fernández-Avilés; Damian García-Olmo; Felipe Prosper; Fermin Sánchez-Guijo; Jose M Moraleda; Agustin G Zapata
Journal:  Front Immunol       Date:  2022-06-09       Impact factor: 8.786

Review 2.  Challenges in Clinical Development of Mesenchymal Stromal/Stem Cells: Concise Review.

Authors:  Ilenia Mastrolia; Elisabetta Manuela Foppiani; Alba Murgia; Olivia Candini; Anna Valeria Samarelli; Giulia Grisendi; Elena Veronesi; Edwin M Horwitz; Massimo Dominici
Journal:  Stem Cells Transl Med       Date:  2019-07-16       Impact factor: 6.940

3.  Sex-Specific Transcriptome Differences in Human Adipose Mesenchymal Stem Cells.

Authors:  Eva Bianconi; Raffaella Casadei; Flavia Frabetti; Carlo Ventura; Federica Facchin; Silvia Canaider
Journal:  Genes (Basel)       Date:  2020-08-08       Impact factor: 4.096

4.  GPX7 Facilitates BMSCs Osteoblastogenesis via ER Stress and mTOR Pathway.

Authors:  Xuchen Hu; Boer Li; Fanzi Wu; Xiaoyu Liu; Mengyu Liu; Chenglin Wang; Yu Shi; Ling Ye
Journal:  J Cell Mol Med       Date:  2021-10-09       Impact factor: 5.310

5.  Activation of the EGFR-PI3K-CaM pathway by PRL-1-overexpressing placenta-derived mesenchymal stem cells ameliorates liver cirrhosis via ER stress-dependent calcium.

Authors:  Se Ho Kim; Jae Yeon Kim; Soo Young Park; Won Tae Jeong; Jin Man Kim; Si Hyun Bae; Gi Jin Kim
Journal:  Stem Cell Res Ther       Date:  2021-10-24       Impact factor: 6.832

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.